“I was in a meeting last week, and I asked a simple question: ‘Is this remarkable?’ They all looked at me. I just said: ‘I want remarkable.’”
The speaker, Kevin Sayer, is President and CEO of Dexcom, Inc. ranked #2 on this year’s Forbes list of Most Innovative Growth Companies (Last year, Dexcom ranked number four.) Sayer, was describing his interaction with some engineering colleagues who were proposing a next-generation product for diabetes patients. Dexcom, a medical device maker based in San Diego, specializes in continuous glucose monitoring solutions. Its G5 Mobile CGM System was a breakthrough when it was launched in 2015, as the first system allowing patients — even young children—to use a smart device to keep track of their glucose levels in real time.
[button open_new_tab=”true” color=”Accent-Color” size=”medium” url=”https://www.forbes.com/sites/halgregersen/2017/05/17/expecting-the-remarkable-at-dexcom/#6d3c2add6d3c” text=”Read More”]